IP Library Granted Patent US 10,226,208
Granted Patent B2
US 10,226,208 · App. 15/177,041 · Granted Mar 12, 2019

Analyte detection devices and methods with hematocrit/volume correction and feedback control

Inventors: Jeffrey L. Emery (Redwood City, CA); Carole R. Stivers (Palo Alto, CA)
Assignee: Intuity Medical, Inc.
A61B5/157A61B5/1455A61B5/1495A61B5/14532A61B5/155A61B5/150358A61B5/6831G01N21/78G01N33/523G01N33/66A61B2562/0295
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,226,208
App. No.
15/177,041
Granted
Mar 12, 2019
Kind
B2
Abstract

Disclosed are devices, arrangements and methods for quantifying the concentration of an analyte present in bodily fluid, including: an assay pad having at least one chemical reagent capable of producing a detectable signal in the form of a reaction spot upon reaction with the analyte; a light source; a detector array; a processor; and a memory in communication with the processor, the memory comprising: (a) at least one value indicative of one or more of: (i) the level of hematocrit contained in the sample; (ii) the volume of the sample applied to the assay pad; or (iii) imperfections present in the reaction spot; and (b) at least one algorithm for calculating the concentration of the analyte contained in the sample.

Claims (46)

1. An arrangement for measuring a concentration of an analyte contained in a sample of body fluid, the arrangement comprising:

an assay pad containing a single chemical reagent, wherein the chemical reagent produces a detectable signal in the form of a color change at a reaction spot formed upon reaction with the analyte, and wherein the concentration of the analyte is measured at the reaction spot;

a light source;

a detector array; and

a processor configured to:

derive a hematocrit level value from the color change at the reaction spot; and

calculate a hematocrit-adjusted analyte concentration using the hematocrit level value.

2. The arrangement of claim 1 , wherein the analyte comprises glucose and the body fluid comprises blood.

3. The arrangement of claim 1 , wherein the detector array is a linear array.

4. The arrangement of claim 1 , wherein the detector array comprises at least one of a linear array, a polar array, and an area array.

5. The arrangement of claim 1 , wherein the detector array comprises a plurality of detector elements, the detector elements comprising CMOS, CCD, photodiode, infrared, fluorescent, or ultraviolet elements.

6. The arrangement of claim 1 , further comprising at least one body fluid sampling catalyst device.

7. The arrangement of claim 6 , wherein the at least one catalyst device comprises at least one of a vacuum pump, a vibration motor, and a heating element.

8. The arrangement of claim 7 , wherein the at least one catalyst device is configured to be responsive to control signals, the control signals based on sample volume calculations.

9. The arrangement of claim 5 , wherein at least a portion of the plurality of detector elements are not in optical registry with the reaction spot and are configured to analyze one or more of a control solution having a known concentration of analyte introduced onto an area of the assay pad that is different from the area of the reaction spot, a standard color producing a known signal, and calibration information specific to the lot of the assay pad.

10. The arrangement of claim 1 further comprising a memory, wherein the processor is further configured to look-up the hematocrit level value in a look-up table stored on the memory.

11. The arrangement of claim 1 , further comprising a needle having a first end configured to pierce skin, and a second end in fluid communication with the assay pad.

12. An analyte monitoring device comprising the arrangement of claim 1 , wherein the arrangement comprises a plurality of assay pads and a plurality of needles, thereby enabling the performance of a plurality of analyte concentration measurements.

13. The analyte monitoring device of claim 12 , further comprising a band for attaching the device to a body of a user.

14. An integrated meter comprising:

at least one piercing element;

at least one actuation member; and

the arrangement of claim 1 .

15. An arrangement for measuring a concentration of an analyte contained in a sample of body fluid, the arrangement comprising:

an assay pad comprising a chemical reagent configured to produce a detectable color change in a reaction with the analyte, wherein the detectable color change is indicative of an analyte level;

a light source;

a detector array; and

a processor configured to:

derive a calibration factor from the detectable color change of the same reaction, wherein the calibration factor is indicative of the level of hematocrit contained in the sample; and

calculate the concentration of the analyte using the analyte level and the calibration factor.

16. The arrangement of claim 15 , wherein the analyte comprises glucose and the body fluid comprises blood.

17. The arrangement of claim 15 , wherein the detector array is a linear array.

18. The arrangement of claim 15 , wherein the detector array comprises at least one of a linear array, a polar array, and an area array.

19. The arrangement of claim 15 , wherein the detector array comprises a plurality of detector elements, the detector elements comprising CMOS, CCD, photodiode, infrared, fluorescent, or ultraviolet elements.

20. The arrangement of claim 15 , further comprising at least one body fluid sampling catalyst device.

21. The arrangement of claim 20 , wherein the at least one catalyst device comprises at least one of a vacuum pump, a vibration motor, and a heating element.

22. The arrangement of claim 21 , wherein the at least one catalyst device is configured to be responsive to control signals, the control signals based on sample volume calculations.

23. The arrangement of claim 19 , wherein at least a portion of the plurality of detector elements are not in optical registry with a reaction spot formed by the reaction and are configured to analyze one or more of a control solution having a known concentration of analyte introduced onto an area of the assay pad that is different from the area of the reaction spot, a standard color producing a known signal, and calibration information specific to the lot of the assay pad.

24. The arrangement of claim 15 further comprising a memory, wherein the processor is further configured to look-up the calibration factor in a look-up table stored on the memory.

25. The arrangement of claim 15 , further comprising a needle having a first end configured to pierce skin, and a second end in fluid communication with the assay pad.

26. An analyte monitoring device comprising the arrangement of claim 15 , wherein the arrangement comprises a plurality of assay pads and a plurality of needles, thereby enabling the performance of a plurality of analyte concentration measurements.

27. The analyte monitoring device of claim 26 , further comprising a band for attaching the device to a body of a user.

28. An integrated meter comprising:

at least one piercing element;

at least one actuation member; and

the arrangement of claim 15 .

Assignments (4)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Apr 5, 2024
From: INTUITY MEDICAL, INC.
To: 302 INTUITY INVESTORS, LLC
Reel/Frame 067025/0798 →
SECURITY INTEREST Recorded May 25, 2021
From: INTUITY MEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 056392/0333 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2017
From: EMERY, JEFFREY L.; STIVERS, CAROLE R.
To: ROSEDALE MEDICAL, INC.
Reel/Frame 041344/0913 →
CHANGE OF NAME Recorded Jan 11, 2017
From: ROSEDALE MEDICAL, INC.
To: INTUITY MEDICAL, INC.
Reel/Frame 041344/0931 →
Continuity (5)
Continuation 14614177 · Feb 4, 2015
Continuation 13037089 · Feb 28, 2011
Continuation 11239122 · Sep 30, 2005
Provisional Application 60689546 · Jun 13, 2005
Related Publication 20170095188A1 · Apr 6, 2017
Cited By (2)
US 12,527,934 US 12,642,936